Assistance Publique-Hopitaux de Paris (AP-HP)

Patent Applications and Registrations

Patent applications and USPTO patent grants for Assistance Publique-Hopitaux de Paris (AP-HP).The latest application filed is for "method of providing celiprolol therapy to a patient".

Company Profile

7.11.13

Assistance Publique-Hopitaux de Paris (AP-HP) - Paris FR
ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (AP-HP) - AP-HP
ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (AP-HP) - Paris OT N/A FR
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) - PRIS CEDEX 10 FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method Of Providing Celiprolol Therapy To A Patient App 20220062208 - Frank; Michael	2022-03-03
Biomarker of the colour perception of a mammal subject based on pupil frequency tagging Grant 11,229,356 - Pouget , et al. January 25, 2	2022-01-25
Optimised generation of MRI images by a multi-antenna MRI system Grant 11,143,729 - Santin October 12, 2	2021-10-12
Use Of Celiprolol For Treating Vascular Ehlers-danlos Syndrome In Women During Pregnancy And Peripartum Period App 20210137859 - Frank; Michael ; et al.	2021-05-13
Biomarker Of The Colour Perception Of A Mammal Subject Based On Pupil Frequency Tagging App 20210076931 - POUGET; Pierre ; et al.	2021-03-18
Optimised Generation Of Mri Images By A Multi-antenna Mri System App 20210072334 - SANTIN; Mathieu	2021-03-11
Method Of Providing Celiprolol Therapy To A Patient App 20210000770 - Frank; Michael	2021-01-07
Process For Multi-analyses Of Rare Cells Extracted Or Isolated From Biological Samples Through Filtration App 20200264166A1 -	2020-08-20
Method For Molecular Typing Of Tumors In A Single Targeted Next Generation Sequencing Experiment App 20200157640A1 -	2020-05-21
Determination Of Chromatic Iso-luminance Information For Controlling A Computer Process In A Personalised Manner App 20200037870 - Pouget; Pierre ; et al.	2020-02-06
Cutting device for endovascular surgery Grant 10,548,623 - Alsac , et al. Fe	2020-02-04
Self Assembling Peptide Matrix for the Prevention of Esophageal Stricture After Endoscopic Dissection App 20190358290 - Gil; Eun Seok ; et al.	2019-11-28
Biomaterial For Therapeutic Use App 20190255219 - Menasche; Philippe ; et al.	2019-08-22
Combined Vaccination/radioterapy For Cancer Treatment App 20190201480 - DEUTSCH; Eric ; et al.	2019-07-04
Method Of Providing Celiprolol Therapy To A Patient App 20190192457 - Frank; Michael	2019-06-27
Use Of Celiprolol For Treating Vascular Ehlers-danlos Syndrome In Women During Pregnancy And Peripartum Period App 20190192456 - Frank; Michael ; et al.	2019-06-27
Combined Vaccination/radioterapy For Cancer Treatment App 20180036368 - DEUTSCH; Eric ; et al.	2018-02-08
Methods for the treatment and diagnosis of bone mineral density related diseases Grant 9,834,820 - Cormier-Daire , et al. December 5, 2	2017-12-05
Cutting Device For Endovascular Surgery App 20150148828 - Alsac; Jean-Marc ; et al.	2015-05-28
Diagnosis method of hepatic steatosis using biochemical markers Grant 7,860,656 - Poynard December 28, 2	2010-12-28
Diagnosis method of alcoholic steato-hepatitis using biochemical markers Grant 7,856,319 - Poynard December 21, 2	2010-12-21
Diagnosis method of inflammatory, fibrotic or cancerous disease using biochemical markers Grant 7,225,080 - Poynard May 29, 2	2007-05-29
Diagnosis method of inflammatory, fibrotic or cancerous disease using biochemical markers Grant 6,631,330 - Poynard October 7, 2	2003-10-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.